Anti-onchocercal properties of three medicinal plants against Onchocerca ochengi

Abstract

Objective: To evaluate the filaricidal properties of three indigenous medicinal plants-Cassia alata, Zornia scabra, and Momordica (M.) foetida, in order to explore their potential as novel sources of filaricides for the sustainable management of filariasis.
Methods: Nine crude extracts from these three plants were prepared and screened in vitro against the microfilariae and adult worms of Onchocerca (O.) ochengi. Viability of O. ochengi adult male worm and mf was ascertained by microscopy while that of adult female worm of O. ochengi was by MTT/formazan assay. Cytotoxicity and acute toxicity were assessed in LLC-MK2 cells and in balb/c mice, respectively.
Results: At the single highest concentration of 500 µg/mL, all the extracts were active on O. ochengi adult males while seven showed activity on adult females and microfilariae. The methylene chloride extract of M. foetida was the most active on O. ochengi with IC_50s of 30.3 µg/mL, 40.3 µg/mL, and 44.2 µg/mL on males, females, and microfilariae, respectively. Selectivity indexes for the most active extract were 3.5 µg/mL (microfilariae), 3.9 µg/mL (females), and 5.1 µg/mL (males). There was no physical sign of acute toxicity and no hepatocellular injury to balb/c mice.
Conclusions: Extracts of Cassia alata, Zheneria scabra and M. foetida contain nematocidal properties with the methylene chloride extract of M. foetida being the most active on the adult worms and juvenile stages of O. ochengi. These findings provide a base for the isolation of anti-filarial lead molecules from the extract.

Keywords

Onchocerciasis / Medicinal plants / Momordica foetida / Selectivity index

Conflict of interest statement

The authors claim there is no conflict of interest.

Funding

This study receives no extramural funding.

Data availability statement

The data supporting the findings of this study are available from the corresponding author upon request.

Authors’ contributions

Samje M designed, performed the experiments, and drafted the manuscript, Ngoufo P collected plants, performed the experiments, and drafted the manuscript, Mfonku N, Tchoufack B, Mbah G and Tiku E performed experiments, Samje M, Mbah G and Ngoufo P analysed data, Cho-Ngwa F supervised and critically review the manuscript. All authors contributed to the final version of the manuscript.

References

[1] Boatin BA, Richards Jr FO. Control of onchocerciasis. Adv Parasitol 2006; 61: 349-394.

[2] GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018; 392(10159): 1789-858.

[3] Peters DH, Phillips T. Mectizan donation program: evaluation of a public-private partnership. Trop Med Int Health 2004; 9(4): A4-15.

[4] Fischer PU, King CL, Jacobson JA, Weil GJ. Potential value of triple drug therapy with ivermectin, diethylcarbamazine, and albendazole (IDA) to accelerate elimination of lymphatic filariasis and onchocerciasis in Africa. PLoS Negl Trop Dis 2017; 11(1): e0005163.

[5] Gardon J, Gardon-Wendel N, Demanga N, Kamgno J, Chippaux JP, et al. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection. Lancet 1997; 350(9070): 18-22.

[6] Taylor MJ, Hoerauf A, Bockarie M. Lymphatic filariasis and onchocerciasis. Lancet 2010; 376(9747): 1175-1185.

[7] Katabarwa M, Eyamba A, Habomugisha P, Lakwo T, Ekobo S, Kamgno J, et al. After a decade of annual dose mass ivermectin treatment in Cameroon and Uganda, onchocerciasis transmission continues. Trop Med Int Health 2008; 13(9): 1196-1203.

[8] Otabil KB, Gyasi SF, Awuah E, Obeng-Ofori D, Atta-Nyarko RJ, Andoh D, et al. Prevalence of onchocerciasis and associated clinical manifestations in selected hypoendemic communities in Ghana following long-term administration of ivermectin. BMC Infect Dis 2019; 19(1): 431.

[9] Katabarwa MN, Eyamba A, Nwane P, Enyong P, Yaya S, Baldiagaï J, et al. Seventeen years of annual distribution of ivermectin has not interrupted onchocerciasis transmission in North Region, Cameroon. Am J Trop Med Hyg 2011; 85(6): 1041-1049.

[10] Bourguinat C, Pion SD, Kamgno J, Gardon J, Duke BO, Boussinesq M, et al. Genetic selection of low fertile Onchocerca volvulus by ivermectin treatment. PLoS Negl Trop Dis 2007; 1(1): e72.

[11] Lustigman S, McCarter JP. Ivermectin resistance in Onchocerca volvulus: Toward a genetic basis. PLoS Negl Trop Dis 2007; 1(1): e76.

[12] Ndjonka D, Ajonina-Ekoti I, Djafsia B, Luersen K, Abladam E, Liebau E. Anogeissus leiocarpus extract on the parasite nematode Onchocerca ochengi and on drug resistant mutant strains of the free-living nematode Caenorhabditis elegans. Vet Parasitol 2012; 190(1-2): 136-142.

[13] Liu M, Panda SK, Luyten W. Plant-based natural products for the discovery and development of novel anthelmintics against nematodes. Biomolecules 2020; 10(3): 426.

[14] Balunas MJ, Kinghorn AD. Drug discovery from medicinal plants. Life Sci 2005; 78(5): 431-441.

[15] Rastelli G, Pellati F, Pinzi L, Gamberini MC. Repositioning natural products in drug discovery. Basel: Multidisciplinary Digital Publishing Institute; 2020.

[16] Ohashi M, Amoa-Bosompem M, Kwofie KD, Agyapong J, Adegle R, Sakyiamah MM, et al. In vitro antiprotozoan activity and mechanisms of action of selected Ghanaian medicinal plants against Trypanosoma, Leishmania, and Plasmodium parasites. Phytother Res 2018; 32(8): 1617-30.

[17] Oyedemi BO, Oyedemi SO, Chibuzor JV, Ijeh II, Coopoosamy RM, Aiyegoro AO. Pharmacological evaluation of selected medicinal plants used in the management of oral and skin infections in Ebem-Ohafia District, Abia State, Nigeria. Sci World J 2018; 2018: 4757458.

[18] Acquaviva R, Di Giacomo C, Vanella L, Santangelo R, Sorrenti V, Barbagallo I, et al. Antioxidant activity of extracts of Momordica foetida Schumach. et Thonn. Molecules 2013; 18(3): 3241-3249.

[19] Adia MM, Emami SN, Byamukama R, Faye I, Borg-Karlson AK. Antiplasmodial activity and phytochemical analysis of extracts from selected Ugandan medicinal plants. J Ethnopharmacol 2016; 186: 14-19.

[20] Chekole G, Asfaw Z, Kelbessa E. Ethnobotanical study of medicinal plants in the environs of Tara-gedam and Amba remnant forests of Libo Kemkem District, northwest Ethiopia. J Ethnobiol Ethnomed 2015; 11: 4.

[21] Obbo CJD, Kariuki ST, Gathirwa JW, Olaho-Mukani W, Cheplogoi PK, Mwangi EM. In vitro antiplasmodial, antitrypanosomal and antileishmanial activities of selected medicinal plants from Ugandan flora: Refocusing into multi-component potentials. J Ethnopharmacol 2019; 229: 127-136.

[22] Tadesse WT, Hailu AE, Gurmu AE, Mechesso AF. Experimental assessment of antidiarrheal and antisecretory activity of 80% methanolic leaf extract of Zehneria scabra in mice. BMC Complement Altern Med 2014; 14: 460.

[23] OECD iLibrary. Organization for Economic Co-operation and Development (OECD) Guidelines for the Testing of Chemicals, Test No. 420: Acute Oral Toxicity-Fixed Dose Procedure. Paris: OECD Publishing; 2002.

[24] Singh D, Singh P, Gupta A, Solanki S, Sharma E, Nema R. Qualitative estimation of the presence of bioactive compound in Centella asiatica: An important medicinal plant. Int J Life Sci Med Sci 2012; 2(1): 4-7.

[25] Trease G, Evans W. Phytochemicals. Pharmacognosy, 15th eds. London: Saunders Publishers; 2002, p. 42-393.

[26] Cho-Ngwa F, Abongwa M, Ngemenya MN, Nyongbela KD. Selective activity of extracts of Margaritaria discoidea and Homalium africanum on Onchocerca ochengi. BMC Complement Altern Med 2010; 10: 62.

[27] Ngwewondo A, Wang M, Manfo FPT, Samje M, Ganin's JN, Ndi E, et al. Filaricidal properties of Lantana camara and Tamarindus indica extracts, and Lantadene A from L. camara against Onchocerca ochengi and Loa loa. PLoS Negl Trop Dis 2018; 12(6): e0006565.

[28] Samje M, Metuge J, Mbah J, Nguesson B, Cho-Ngwa F. In vitro anti-Onchocerca ochengi activities of extracts and chromatographic fractions of Craterispermum laurinum and Morinda lucida. BMC Complement Altern Med 2014; 14: 325.

[29] Bulman CA, Bidlow CM, Lustigman S, Cho-Ngwa F, Williams D, Rascon AA, Jr., et al. Repurposing auranofin as a lead candidate for treatment of lymphatic filariasis and onchocerciasis. PLoS Negl Trop Dis 2015; 9(2): e0003534.

[30] Comley JC, Townson S, Rees MJ, Dobinson A. The further application of MTT-formazan colorimetry to studies on filarial worm viability. Trop Med Parasitol 1989; 40(3): 311-316.

[31] Metuge JA, Nyongbela KD, Mbah JA, Samje M, Fotso G, Babiaka SB, et al. Anti-Onchocerca activity and phytochemical analysis of an essential oil from Cyperus articulatus L. BMC Complement Altern Med 2014; 14: 223.

[32] Gilbert J, Nfon CK, Makepeace BL, Njongmeta LM, Hastings IM, Pfarr KM, et al. Antibiotic chemotherapy of onchocerciasis: in a bovine model, killing of adult parasites requires a sustained depletion of endosymbiotic bacteria (Wolbachia species). J Infect 2005; 192(8): 1483-1493.

[33] Sahoo N, Manchikanti P, Dey S. Herbal drugs: standards and regulation. Fitoterapia 2010; 81(6): 462-471.

[34] Chatterjee S, Chatterjee S, Dutta S. An overview on the ethnophytopathological studies of cassia alata: An important medicinal plant and the effect of VAM on its growth and productivity. Int J Res Bot 2012; 2(4): 13-19.

[35] Mukazayire M, Allaeys V, Buc Calderon P, Stévigny C, Bigendako M, Duez P, et al. Ethnobatanic study around volcanoes National Park of Rwanda. New York Sci J 2010; 3: 37-49.

[36] Moshi MJ, Otieno DF, Weisheit A. Ethnomedicine of the Kagera Region, north western Tanzania. Part 3: Plants used in traditional medicine in Kikuku village, Muleba District. J Ethnobiol Ethnomed 2012; 8(1): 14.

[37] Burkill HM. The useful plants of West Tropical Africa. Vol. 1. Families AD: Royal Botanic Gardens. Charlottesville: University Press of Virginia; 1985.

[38] Sayyah M, Hadidi N, Kamalinejad M. Analgesic and anti-inflammatory activity of Lactuca sativa seed extract in rats. J Ethnopharmacol 2004; 92(2-3): 325-329.

[39] Oskoueian E, Abdullah N, Ahmad S, Saad WZ, Omar AR, Ho YW. Bioactive compounds and biological activities of Jatropha curcas L. kernel meal extract. Int J Mol Sci 2011; 12(9): 5955-5970.

[40] Cho-Ngwa F, Monya E, Azantsa BK, Manfo FP, Babiaka SB, Mbah JA, et al. Filaricidal activities on Onchocerca ochengi and Loa loa, toxicity and phytochemical screening of extracts of Tragia benthami and Piper umbellatum. BMC Complement Altern Med 2016; 16(1): 326.

[41] Kalmobé J, Ndjonka D, Dikti JV, Liebau E. Antifilarial activity of Cucurbita pepo ovifera var ovifera (Cucurbitaceae) on Onchocerca ochengi adult worms. Br J Pharm Res Int 2017; 17(2): 1-8.

[42] Ndjonka D, Abladam ED, Djafsia B, Ajonina-Ekoti I, Achukwi MD, Liebau E. Anthelmintic activity of phenolic acids from the axlewood tree Anogeissus leiocarpus on the filarial nematode Onchocerca ochengi and drug-resistant strains of the free-living nematode Caenorhabditis elegans. J Helminthol 2014; 88(4): 481-488.

[43] Ngwewondo A, Tsague Manfo FP, Samje M, Monya E, Cho-Ngwa F. Macro and microfilaricidal activities of extracts of Annona senegalensis and Milletia comosa against Onchocerca ochengi and Loa loa. Exp Parasitol 2019; 198: 71-78.